The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous ...

Stocks continued to be under pressure as investors navigated the uncertainty surrounding tariffs and growing concerns about a recession. The S&P 500 officially moved into correction territory, marked ...

We have therefore made the assessment that COVID-19 can be characterized as a pandemic," he says. During the first European ...

Everest Medicines has dosed the first subject with EVM16, the company’s personalised mRNA cancer vaccine, in the EVM16CX01 ...

EVM16 is a novel personalized therapeutic mRNA cancer vaccine internally developed by Everest. It contains neoantigens with high immunogenicity potential, predicted based on the unique tumor ...

China “must enhance its political capabilities and calmly respond to challenges brought about by changes in the domestic and international situation”, Mr Xi told top officials, including ...

(NASDAQ:MRNA) stands against the other best vaccine ... he did say that anything coming out of Europe or China would obviously be fair game. The pharmaceutical companies would say that the ...

NEW YORK -- Fund managers are wary of the Trump administration's latest push to restrict U.S. investments into China, which could extend to publicly traded securities. President Donald Trump on ...

The administration is positioning itself to clamp down on Chinese investment and access to technology. But the wild card may be the president himself. By Ana Swanson Ana Swanson covers ...

Editor’s Note: Sign up for CNN’s Meanwhile in China newsletter which explores what you need to know about the country’s rise and how it impacts the world. But the head-spinning set of moves ...

China and Russia “cannot be moved away” from one another, Chinese leader Xi Jinping told his counterpart Vladimir Putin on Monday, in their first phone call since US President Donald Trump ...